EUDRAVIGILANCE at 1,070,631 VAERS at 624,234 , Bee Venom, Lactoferrin and oral rhabdoviral vaccine
Channel: VHFILM
Date: 2021-10-24

00:00 Open with breaking report  'Pfizer Reserves the Right to Silence Governments" from Public Citizen in reference to Vaccine contracts.
03:30 Forward look at till what will be covered
09:58 Review of Data Sources, PLUS VAERS Disclaimer
12:01 VAERS zip file reports for 2021, now 16% larger than the prior 30 years combined.
13:80 Both Compounds from Bacillus and Bee Venom massively outperform Remedisver in vitro while maintaining low or no cytotoxicity  
18:35 Lactoferrin may work best as a chewable or oral dissolvable for RTI's
23:17 Oral Rhabdoviral Medicine/ or vaccine may offer long-lasting powerful protection
29:16 Quote " Nearly one-third (31.4%) of COVID-19 vaccine recipients reported having trouble taking care of themselves" from How frequent are acute reactions to COVID-19 vaccination and who is at risk?
36:40 The mystery of the Provincetown Massachusetts outbreak
42:54 New study provides robust evidence that COVID-19 is a seasonal infection
45:08  ‘Generation Lockdown’ needs targeted help-to-work policies – global report
46:38 THE LANCET: Urgent action needed to integrate climate change mitigation into COVID-19 recovery plans to address global inequities in health and build a sustainable future
47:35  Israeli physicians, scientists advise FDA of ‘severe concerns’ regarding reliability and legality of official Israeli COVID vaccine data ( America's Frontline Doctors )
54:42 Public Citizen - Investigation "Pfizer's Power"
55:31 VAERS DISCLAIMER
55:51 Onward toward Global and National Data Comparisons



Data Sources:
GISAID
HEALTHDATA GOV
CDC
OUR WORLD IN DATA
VAERS
EUDRAVIGILANCE

#BeeVenom #Lactoferrin #bacillus

Gramicidin S and Melittin - Potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
https://www.biorxiv.org/content/10.1101/2021.10.21.465254v1

Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections
https://www.eurekalert.org/news-releases/932115

Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
https://www.biorxiv.org/content/10.1101/2021.10.16.464660v1.full

How frequent are acute reactions to COVID-19 vaccination and who is at risk?
https://www.medrxiv.org/content/10.1101/2021.10.14.21265010v1.full

Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
https://www.medrxiv.org/content/10.1101/2021.10.20.21265137v1.full

New study provides robust evidence that COVID-19 is a seasonal infection
https://www.eurekalert.org/news-releases/932024

‘Generation Lockdown’ needs targeted help-to-work policies – global report
https://www.eurekalert.org/news-releases/932334

THE LANCET: Urgent action needed to integrate climate change mitigation into COVID-19 recovery plans to address global inequities in health and build a sustainable future
https://www.eurekalert.org/news-releases/931882

Israeli physicians, scientists advise FDA of ‘severe concerns’ regarding reliability and legality of official Israeli COVID vaccine data
https://americasfrontlinedoctors.org/2/frontlinenews/breaking-israeli-physicians-scientists-advise-fda-of-severe-concerns-regarding-reliability-and-legality-of-official-israeli-covid-vaccine-data/

Pfizer’s Power
https://www.citizen.org/article/pfizers-power/#_ftn14